Elevance Health

YTD

ALL

Trade Elevance Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ELV

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other.

CEO

Gail Koziara Boudreaux

CEOGail Koziara Boudreaux

Employees

97,100

Employees97,100

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1944

Founded1944

Employees

97,100

Employees97,100

ELV Key Statistics

Market cap

91.60B

Market cap91.60B

Price-Earnings ratio

18.39

Price-Earnings ratio18.39

Dividend yield

1.59%

Dividend yield1.59%

Average volume

1.58M

Average volume1.58M

High today

$434.38

High today$434.38

Low today

$422.91

Low today$422.91

Open price

$431.34

Open price$431.34

Volume

380.56K

Volume380.56K

52 Week high

$450.69

52 Week high$450.69

52 Week low

$274.84

52 Week low$274.84

Stock Snapshot

The current Elevance Health(ELV) stock price is $423.98, with a market capitalization of 91.6B. The stock trades at a price-to-earnings (P/E) ratio of 18.39 and offers a dividend yield of 1.59%.

On 2026-10-27, Elevance Health(ELV) stock traded between a low of $422.91 and a high of $434.38. Shares are currently priced at $423.98, which is +0.3% above the low and -2.4% below the high.

Elevance Health(ELV) shares are trading with a volume of 380.56K, against a daily average of 1.58M.

During the past year, Elevance Health(ELV) stock moved between $274.84 at its lowest and $450.69 at its peak.

ELV News

Zacks 1d

Implied Volatility Surging for Elevance Health Stock Options - Zacks Investment Research

...

Simply Wall St 3d

How Investors Are Reacting To Elevance Health Raised Earnings Guidance

Elevance Health reported Q3 2026 revenue of US$51.4b and net income of US$1.4b, raised full year diluted EPS guidance to at least US$22.00, and affirmed a US$1....

TipRanks 5d

Elevance Health price target raised to $485 from $460 at Guggenheim

Guggenheim analyst Jason Cassorla raised the firm’s price target on Elevance Health (ELV) to $485 from $460 and keeps a Buy rating on the shares, stating that E...

Analyst ratings

60%

of 25 ratings

Buy

60%

Hold

40%

Sell

More ELV News

Simply Wall St 5d

Elevance Health Raised Its 2026 Earnings Outlook After Strong Q3 Results

Elevance Health (NYSE: ELV) reported stronger than expected Q3 earnings, prompting an update to its long-term plans on Thursday, 22 Oct 2026. Management raised...

People also own

Based on the portfolios of people who own ELV. This list is generated using Robinhood data, and it’s not a recommendation.

Brookfield Corporation

Berkshire Hathaway Inc. C…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.